Search Results for 'study fda'

study fda published presentations and documents on DocSlides.

Preparing for an FDA Inspection
Preparing for an FDA Inspection
by min-jolicoeur
. Kathy Gilmartin, MSN, CRN...
Preparing for an FDA Inspection
Preparing for an FDA Inspection
by tawny-fly
. Kathy Gilmartin, MSN, CRN...
Preparing for an FDA Inspection
Preparing for an FDA Inspection
by felicity
. Kathy Gilmartin, MSN, CRNP, CCRC. ...
Sponsor-Investigator (SI) FDA Inspections
Sponsor-Investigator (SI) FDA Inspections
by eurolsin
Christiana Provencal, M.A.. Quality Assurance / Qu...
FDA  Pre-Submission Meetings
FDA Pre-Submission Meetings
by violet
for 510(k) Submissions. Consultants and RA Experts...
The FDA is Coming Neala  Lane, MS, CCRC
The FDA is Coming Neala Lane, MS, CCRC
by joy
Associate Director. Quality Improvement Office. Of...
FDA Regulatory Requirements for Successful Biomarker Applications
FDA Regulatory Requirements for Successful Biomarker Applications
by oliver
Early Detection Research Network. September 9, 201...
ROMA  –  Overview and FDA Lessons
ROMA – Overview and FDA Lessons
by tristan742
Clinical Situation: . A woman with a pelvic mass. ...
Investigator Responsibilities for Research
Investigator Responsibilities for Research
by trish-goza
Shannon Simmons, BA, CIP. March 14, 2014. Process...
Everyday Preparedness for the
Everyday Preparedness for the
by tatiana-dople
Challenges . of . FDA-Regulated . Research. Pat W...
Welcome Once you’ve logged into
Welcome Once you’ve logged into
by dora
Webex. , please select one of the following audio ...
Guidance for Clinical Investigators Sponsors and Investigational New D
Guidance for Clinical Investigators Sponsors and Investigational New D
by jade
NOTE A stay is in effect for partsof subsection V...
The Rare Disease Treatment Approval Process:
The Rare Disease Treatment Approval Process:
by lily
Balancing Gold Standard Evidence with Patient-Cent...
Clinical/Surrogate Endpoints and Innovative Approaches for Catheter Ablation Studies
Clinical/Surrogate Endpoints and Innovative Approaches for Catheter Ablation Studies
by SugarPlumFairy
FDA Perspective. Marco Cannella, PhD. Senior Lead ...
TABLE OF CONTENTS
TABLE OF CONTENTS
by tracy
I. INTRODUCTION .....................................
Writing and Holding an IND- IIT Development
Writing and Holding an IND- IIT Development
by osullivan
Week 3- Proposing and Conducting a Clinical Trial....
Karen Davis-Bruno  Ph.D  (FDA/CDER/OND)
Karen Davis-Bruno Ph.D (FDA/CDER/OND)
by isabella2
Melissa Tassinari . Ph.D. (FDA/CDER/OND/DPMH). Jac...
Presentation To : The Jackson Laboratory
Presentation To : The Jackson Laboratory
by isla
Chris Hempel. Addi & Cassi Fund. A Family’s ...
Regulatory Environment for
Regulatory Environment for
by mila-milly
Alzheimers. Therapeutics . (and Diagnostics). Mar...
A Bayesian Approach in Design and Analysis of Pediatric Cancer Clinical Trials
A Bayesian Approach in Design and Analysis of Pediatric Cancer Clinical Trials
by adah
Jingjing Ye, PhD. BeiGene. PSI Journal Club: Bayes...
Registry Kobayashi Cardiology Childrens Hospital Associate Professor
Registry Kobayashi Cardiology Childrens Hospital Associate Professor
by nathanael
How Are They Set Up?. Daisuke Kobayashi, MD, MPH, ...
 1 Pediatric Clinical Investigator Training
1 Pediatric Clinical Investigator Training
by lois-ondreau
GCP: . Tips on Clinical Trial Conduct and . Prepa...
     UC DAVIS OFFICE OF RESEARCH
UC DAVIS OFFICE OF RESEARCH
by olivia-moreira
Overview of Good Clinical Practices (GCP) . Inves...
Clinical Trial Data Integrity:
Clinical Trial Data Integrity:
by phoebe-click
Bi. oresearch . Mo. nitoring Program. Jur Strobos...
Global Regulatory Affairs
Global Regulatory Affairs
by min-jolicoeur
US . vs. EU. Nariko Koto, MBA. Global Regulatory/...
educate • fund • connect • support
educate • fund • connect • support
by briana-ranney
MIAP – Introduction to INDs and IDEs. E Mitchel...
Would the FDA approve Normal Saline Today?
Would the FDA approve Normal Saline Today?
by yoshiko-marsland
Brad Nichol M.D.. Valley View Hospital. Would the...
My Experiences as an FDA Statistician
My Experiences as an FDA Statistician
by aaron
Yeh-Fong Chen, Ph.D. . FDA/CDER/OB/DB3. CBA 2016-...
The IND and Clinical Trial Management
The IND and Clinical Trial Management
by kittie-lecroy
Frances Richmond . Director International Center ...
1 Structure and mandate of FDA
1 Structure and mandate of FDA
by sherrill-nordquist
Leonard Sacks. Office of Medical Policy. CDER, FD...
SHEDDING LIGHT ON AN
SHEDDING LIGHT ON AN
by olivia-moreira
SHEDDING LIGHT ON AN FDA VISIT Joyce Nancarrow Tu...
Clinical and Nonclinical Inspections
Clinical and Nonclinical Inspections
by claire
n and Research or CBER conducting clinical resear...
Session 8:   Study Start-up: Part 2
Session 8: Study Start-up: Part 2
by gabriella
Derita: . dbran@uthsc.edu. Margaret: . mlynn@ut...
Requirement for Investigators and Sub-Investigators to File Financial Disclosure Forms
Requirement for Investigators and Sub-Investigators to File Financial Disclosure Forms
by lydia
Investigator of Record – Definition. “The indi...
Working with Investigational Assay Results
Working with Investigational Assay Results
by phoebe
Week 6- Correlative Trials- A Case Based Approach....
The Fundamentals of Clinical Research
The Fundamentals of Clinical Research
by harper
Prepared by Christine Hunter, BSN Baylor College ...
Good Clinical Practices Marianne Kearney Chase
Good Clinical Practices Marianne Kearney Chase
by jubilantbikers
Director of Research Operations. Neurological Clin...
Clinical Events Committee Quality
Clinical Events Committee Quality
by cheryl-pisano
and Audit Readiness. Duke/Stanford CEC Summit. Ch...
Investigator Responsibilities for Research
Investigator Responsibilities for Research
by debby-jeon
Jan Zolkower, MSHL, CIP, CCRP. January 13, 2012...
Navigating the differences between
Navigating the differences between
by celsa-spraggs
Investigator-Initiated . v. Sponsor-Initiated Cli...